Early enteral immunonutrition in patients with severe sepsis
- 938 Downloads
To compare the mortality of critically ill patients given either enteral feeding with an immune-enhancing formula or parenteral nutrition (PN). We report the results of a planned interim analysis on patients with severe sepsis which was undertaken earlier than planned once a meta-analysis suggested excess mortality in patients with severe sepsis given enteral immunonutrition.
Randomised multicentre unblinded controlled clinical trial.
Thirty-three General Intensive Care Units in Italy.
Patients and participants
Among the 237 recruited patients, 39 had severe sepsis or septic shock; 21 of them received PN.
Eligible patients received either total PN or enteral nutrition, the latter containing extra L-arginine, omega-3 fatty acids, vitamin E, beta carotene, zinc, and selenium.
Measurements and results
The primary endpoint for the subgroup analysis on patients with severe sepsis was mortality on Intensive Care Unit (ICU). The ICU mortality of patients with severe sepsis given enteral nutrition (EN) was higher than for those given PN (44.4% vs 14.3%; p=0.039). More patients given EN than patients given PN still had severe sepsis when they died (38.9% vs 9.5%, p=0.055). Recruitment of patients with severe sepsis was subsequently stopped.
Our results show that enteral immunonutrition, compared to PN, may be associated with excess mortality in patients with severe sepsis.
KeywordsCritically ill patients Enteral nutrition Parenteral nutrition Immunonutrition Severe sepsis
- 1.Preiser JC, Berre J, Carpentier Y, Jolliet P, Pichard C, Van Gossum A, Vincent JL (1999) Management of nutrition in European intensive care units: results of a questionnaire. Working Group on Metabolism and Nutrition of the European Society of Intensive Care Medicine. Intensive Care Med 25:95–101CrossRefGoogle Scholar
- 10.Heyland DK (2000) Enteral and parenteral nutrition in the seriously ill, hospitalized patient: a critical review of the evidence. J Nutr Health Aging 1:31–41Google Scholar
- 16.Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655CrossRefGoogle Scholar
- 17.Vincent JL, Moreno R, Takala J, Willatts S, De Mendoca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Medi 22:707–710CrossRefGoogle Scholar
- 20.Human Medicines Evaluation Unit (1996) ICH topic E6: guideline for good clinical practice. European Agency for the Evaluation of Medical Products, London, pp 17–20Google Scholar
- 22.Mantel N (1963) Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc J 58:690–700Google Scholar
- 23.Kleinbaum DG, Kupper LL, Morgenstern H (1982) Epidemiologic research. Principles and quantitative methods. Van Nostrand Reinhold, New York, pp 296–297Google Scholar
- 24.Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York, pp 68–71Google Scholar
- 30.Suchner U, Heyland DK, Peter K (2002) Immune-modulatory actions of arginine in the critically ill. Br J Nutr 87[Suppl 1]:121–132Google Scholar